Very few people who could benefit from lung cancer screening – mostly current and former smokers – are actually getting the tests, according to findings from American Cancer Society researchers.
In the Spring of 2015, more than 35 of the nation’s leading cancer researchers joined an unprecedented effort to improve lung cancer treatment. The Lung Cancer Dream Team, as it’s known, is specifically focused on a difficult-to-treat lung cancer with a common gene mutation called KRAS, which occurs in 20-30% of lung cancers.
Researchers at the University of Alabama at Birmingham School of Medicine have recently discovered a new, non-coding gene that may play a key role in causing lung cancer.
FDA approves Xalkori (crizotinib) for treatment of ROS1-positive non-small cell lung cancer. Here’s how American Cancer Society research contributed.